Rezolute (RZLT) Interest Expenses (2012 - 2019)
Rezolute's (RZLT) quarterly Interest Expenses came in at $4.3 million in Q2 2019, up 576.3% year-on-year from $635490.0 in Q2 2018, and down 27.16% quarter-over-quarter from $5.9 million in Q1 2019.
Rezolute (RZLT) Interest Expenses (2012 - 2019) Analysis & Trends
Rezolute has disclosed Interest Expenses across 8 years of filings, most recently posting $4.3 million for Q2 2019.
- Interest Expenses for Q2 2019 came in at $4.3 million, up 576.3% year-over-year; the trailing twelve-month figure through Mar 2020 was $4.3 million (down 50.79% YoY), and the FY2021 annual result was $375000.0, changed N/A from the prior year.
- Interest Expenses came in at $4.3 million for Q2 2019 at Rezolute, down from $5.9 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $5.9 million in Q1 2019 to a low of $147.0 in Q4 2017.
- The 5-year median for Interest Expenses is $1965.0 (2015), against an average of $935455.3.
- Across the five-year window, Interest Expenses slumped 99.94% in 2015 and jumped 876090.48% in 2018, its largest moves.
- Rezolute's Interest Expenses stood at $1379.0 in 2015, then climbed by 15.66% to $1595.0 in 2016, then slumped by 90.78% to $147.0 in 2017, then surged by 876090.48% to $1.3 million in 2018, then surged by 233.68% to $4.3 million in 2019.
- The last three Interest Expenses figures came in at $4.3 million (Q2 2019), $5.9 million (Q1 2019), and $1.3 million (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 4.30 Mn |
| Jun 30, 2019 | 4.30 Mn |
| Mar 31, 2019 | 5.90 Mn |
| Mar 31, 2019 | 5.90 Mn |
| Dec 31, 2018 | 1.29 Mn |
| Dec 31, 2018 | 1.29 Mn |
| Sep 30, 2018 | 911,000.00 |
| Sep 30, 2018 | 911,000.00 |
| Jun 30, 2018 | 635,490.00 |
| Jun 30, 2018 | 635,490.00 |
| Mar 31, 2018 | 53,363.00 |
| Mar 31, 2018 | 53,363.00 |
| Dec 31, 2017 | 147.00 |
| Dec 31, 2017 | 147.00 |
| Sep 30, 2016 | 1,595.00 |
| Sep 30, 2016 | 1,595.00 |
| Jun 30, 2016 | 904.00 |
| Jun 30, 2016 | 904.00 |
| Mar 31, 2016 | 1,143.00 |
| Mar 31, 2016 | 1,143.00 |